Truvestments Capital LLC Neoleukin Therapeutics, Inc. Transaction History

Truvestments Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $269 - $520	-391 Reduced 29.71%	925 $1,000
Q2 2022 Aug 09, 2022	BUY	$0.92 - $2.25 $1,210 - $2,961	1,316 New	1,316 $1,000
Q1 2022 May 02, 2022	SELL	$1.72 - $5.23 $2,263 - $6,882	-1,316 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$10.17 - $14.56 $13,383 - $19,160	1,316 New	1,316 $18,000
Q3 2020 Nov 13, 2020	SELL	$9.68 - $17.01 $12,738 - $22,385	-1,316 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$9.95 - $17.05 $13,094 - $22,437	1,316 New	1,316 $21,000
Q4 2019 Jan 29, 2020	SELL	$2.65 - $12.72 $5,978 - $28,696	-2,256 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$2.33 - $3.76 $5,256 - $8,482	2,256 New	2,256 $6,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.